Eric I. Richman
2013 - PharmAthene
In 2013, Eric I. Richman earned a total compensation of $986K as President and CEO at PharmAthene, a 37% increase compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $68,428 |
|---|---|
| Option Awards | $455,600 |
| Salary | $456,187 |
| Other | $5,750 |
| Total | $985,965 |
Richman received $456.2K in salary, accounting for 46% of the total pay in 2013.
Richman also received $68.4K in non-equity incentive plan, $455.6K in option awards and $5.8K in other compensation.
Rankings
In 2013, Eric I. Richman's compensation ranked 6,694th out of 12,286 executives tracked by ExecPay. In other words, Richman earned more than 45.5% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 6,694 out of 12,286 | 46th |
Division Manufacturing | 2,360 out of 4,612 | 49th |
Major group Chemicals And Allied Products | 705 out of 1,462 | 52nd |
Industry group Drugs | 516 out of 1,156 | 55th |
Industry Pharmaceutical Preparations | 410 out of 890 | 54th |
Source: SEC filing on April 29, 2016.
Richman's colleagues
We found four more compensation records of executives who worked with Eric I. Richman at PharmAthene in 2013.